Vendor, Tsim Sha Tsui, HKG, part of Wuxi Apptec Co.,ltd.
Wuxi Apptec (Hongkong) Limited
UEI JKRKL5UBGYY5, CAGE SAQJ8
3 awards and -$52,537 obligated between July 2, 2024 and November 14, 2024, 0% under full and open competition, against 2.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Food and Drug Administration | -$737 |
| National Institutes of Health | -$51,800 |
Industries
NAICS on the awards, by dollars.
| Medical LaboratoriesNAICS 621511 | -$737 |
| All Other Miscellaneous Chemical Product and Preparation ManufacturingNAICS 325998 | -$22,000 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$29,800 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 2 |
| Not Competed | 1 |
| Purchase Order | 3 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40121P00627Purchase Order, November 14, 2024, Not Competed, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Mission of the Division of Toxicology (Dot) in the Office of Applied Research and Safety Assessment (Oarsa), Center for Food Safety and NAICS 621511, PSC Q301 | -$737 |
| 75N95019P00046Purchase Order, August 14, 2024, Competed Under SAP, 2 offers | National Institutes of Health NidaNational Institutes of Health | To Obtain 200 MG of Compound Synthesis of Small Molecule MarizomibNAICS 325998, PSC 6810 | -$22,000 |
| 75N93019P00134Purchase Order, July 2, 2024, Competed Under SAP, 3 offers | National Institutes of Health NiaidNational Institutes of Health | Ambis # 1933409 Synthesis of Custom Drug KD025NAICS 541715, PSC 6505 | -$29,800 |
- Places of performance
- Maryland
- Product and service codes
- Q301 Reference Laboratory Testing6810 Chemicals6505 Drugs and Biologicals
- Transactions
- 3 across 3 awards